SCHEMBL30964709

SCHEMBL30964709

CCCCCCCCCCN(CCCCCCCCCC)OC(=O)CCC

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DNM1 Q05193 1/20 0.44
DGKA P23743 1/20 0.44
ALDH1A1 P00352 3/20 0.43
CES2 O00748 3/20 0.41
CES1 P23141 3/20 0.41
LMNA P02545 2/20 0.41
KDM5A P29375 1/20 0.41
PPARG P37231 6/20 0.40
PPARD Q03181 6/20 0.40
PPARA Q07869 6/20 0.40
HDAC11 Q96DB2 5/20 0.40
TSHR P16473 4/20 0.40
GPR84 Q9NQS5 4/20 0.40
TLR2 O60603 2/20 0.40
TDP1 Q9NUW8 2/20 0.40
FABP4 P15090 2/20 0.40
PTPN1 P18031 2/20 0.40
PAM P19021 2/20 0.40
SLC22A6 Q4U2R8 1/20 0.40
SLC22A8 Q8TCC7 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7799203 0.94 DNM1 (0.46) DNM1DGKAALDH1A1CES2CES1
SCHEMBL28657236 0.92 DGKA (0.53) DNM1DGKAALDH1A1CES2CES1
SCHEMBL29163447 0.92 ALDH1A1 (0.46) DNM1DGKAALDH1A1CES2CES1
SCHEMBL29134093 0.89 DNM1 (0.42) DNM1DGKAALDH1A1CES2CES1
SCHEMBL29115852 0.88 DGKA (0.53) DNM1DGKAALDH1A1CES2CES1
SCHEMBL29115707 0.88 DGKA (0.53) DNM1DGKAALDH1A1CES2CES1
SCHEMBL28069057 0.88 DGKA (0.53) DNM1DGKAALDH1A1CES2CES1
SCHEMBL6312523 0.86 DNM1 (0.50) DNM1DGKAALDH1A1CES2CES1
SCHEMBL28214917 0.86 DNM1 (0.50) DNM1DGKAALDH1A1CES2CES1
SCHEMBL24728779 0.85 DNM1 (0.47) DNM1DGKAALDH1A1LMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118317944-A Acyclic lipids and methods of use thereof 雷纳嘉德医疗管理公司 2024-07-09 CN disclosed
CN-118234707-A Cyclic lipids and methods of use thereof 雷纳嘉德医疗管理公司 2024-06-21 CN disclosed